Moore Capital Management »

Phathom Pharmaceuticals shares owned by Moore Capital Management

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $913k 100k 9.13
2023-09-30 $830k 80k 10.37
2023-06-30 $859k 60k 14.32

More positions owned by Moore Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Spdr Ser Tr S&p Biotech (XBI)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Ally Financial (ALLY)
Allstate Corporation (ALL)
Spdr Ser Tr S&p Regl Bkg (KRE)
Vaneck Etf Trust Gold Miners Etf (GDX)
salesforce (CRM)
Progressive Corporation (PGR)
Vertiv Holdings Com Cl A (VRT)
Select Sector Spdr Tr Indl Call Option (XLI)

View all positions for Moore Capital Management

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management
Checkpoint Capital

View all funds holding Phathom Pharmaceuticals